Positivity to Cocaine and/or Benzoylecgonine in Confirmation Analyses for On-Road Tests in Spain
- PMID: 34070008
- PMCID: PMC8157855
- DOI: 10.3390/ijerph18105371
Positivity to Cocaine and/or Benzoylecgonine in Confirmation Analyses for On-Road Tests in Spain
Abstract
We are using real-life data in order to determine the prevalence of driving with the presence of cocaine and/or benzoylecgonine (BZE), their concentrations, and their use in combination with other drugs. This study assessed data on Spanish drivers with confirmed drug-positive results recorded by the Spanish National Traffic Agency from 2011-2016. Frequencies of positivity for cocaine and/or BZE and concentration of such substances were obtained. Comparisons and univariate and multivariate regression analyses were performed. Drivers who tested positive for cocaine and/or BZE accounted for 48.59% of the total positive results for drugs. In positive cases for both cocaine and BZE, other substances were detected in 81.74%: delta-9-tetrahydrocannabinol (THC) (68.19%), opioids (20.78%) and amphetamine-like substances (16.76%). In the multivariate logistic regression analysis, the frequency of cocaine and/or BZE positive cases decreased with age (OR:0.97) and were less likely among women (OR:0.63). Concentrations (ng/mL) of cocaine (249.30) and BZE (137.90) were higher when both substances were detected together than when detected alone. Positivity to cocaine represented an important proportion among Spanish drivers who tested positive for drugs, and polysubstance use was especially observed in more than 8 out of 10 positive cases for cocaine and/or BZE.
Keywords: automobile driving; cocaine; driving under the influence; epidemiology; oral fluid; psychotropic drugs; saliva; street drug testing; substance abuse detection.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
Similar articles
-
Cocaine and benzoylecgonine concentrations in fluorinated plasma samples of drivers under suspicion of driving under influence.Forensic Sci Int. 2010 Jul 15;200(1-3):67-72. doi: 10.1016/j.forsciint.2010.03.032. Epub 2010 Apr 24. Forensic Sci Int. 2010. PMID: 20456881
-
Drivers who tested positive for cannabis in oral fluid: a longitudinal analysis of administrative data for Spain between 2011 and 2016.BMJ Open. 2019 Aug 26;9(8):e026648. doi: 10.1136/bmjopen-2018-026648. BMJ Open. 2019. PMID: 31455697 Free PMC article.
-
Concentrations of cocaine and its major metabolite benzoylecgonine in blood samples from apprehended drivers in Sweden.Forensic Sci Int. 2008 May 20;177(2-3):133-9. doi: 10.1016/j.forsciint.2007.11.009. Epub 2007 Dec 31. Forensic Sci Int. 2008. PMID: 18164886
-
Benzodiazepines in the oral fluid of Spanish drivers.Subst Abuse Treat Prev Policy. 2020 Feb 24;15(1):18. doi: 10.1186/s13011-020-00260-y. Subst Abuse Treat Prev Policy. 2020. PMID: 32093743 Free PMC article.
-
Statistical Analysis of Toxicological Data of Victims of Traffic Accidents in Galicia (Spain).Prev Sci. 2023 May;24(4):765-773. doi: 10.1007/s11121-023-01502-8. Epub 2023 Feb 9. Prev Sci. 2023. PMID: 36757660 Free PMC article. Review.
Cited by
-
Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019.Pharmaceuticals (Basel). 2023 Mar 29;16(4):508. doi: 10.3390/ph16040508. Pharmaceuticals (Basel). 2023. PMID: 37111265 Free PMC article.
References
-
- World Health Organization (WHO) Drug Use and Road Safety: A Policy Brief. WHO; Geneva, Switzerland: 2016. [(accessed on 20 March 2021)]. Available online: http://apps.who.int/iris/bitstream/10665/249533/1/WHO-MSD-NVI-2016.01-en....
-
- Schulze H., Shumacher M., Urmeew R., Auerbach K., Alvarez F.J., Bernhoft I.M., De Gier H., Hagenzieker M., Houwing S., Knoche A., et al. Driving Under the Influence of Drugs, Alcohol and Medicines in Europe Findings from the DRUID Project. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); Lisbon, Portugal: 2012.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical